{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-395556","form_type":"8-K","ticker":"BSEM","cik":"0001658678","company_name":"BioStem Technologies, Inc.","filed_at":"2026-09-18T20:15:16+00:00","discovered_at":"2026-09-18T20:16:34.884501+00:00","generated_at":"2026-09-18T20:17:15.669272+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioStem secures up to $40M committed equity facility with Roth Principal Investments","bullets":["Facility allows BioStem to sell up to $40M shares at its discretion over a 36-month term.","Market Open/Intraday purchases priced at 3% VWAP discount; Pre/Post-Market at 5% discount.","Pays $400k cash commitment fee (1% of facility) plus $75k legal and $50k QIU fees.","Exchange cap of 19.99% (3,585,375 shares) unless avg price >=$4.3056 or shareholder approval.","Proceeds intended for working capital and general corporate purposes; no obligation to draw."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-395556","json":"https://secwatch.observer/filing/0001193125-26-395556.json","markdown":"https://secwatch.observer/filing/0001193125-26-395556.md","text":"https://secwatch.observer/filing/0001193125-26-395556.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658678/000119312526395556/0001193125-26-395556-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658678/000119312526395556/bsem-20260918.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-18T20:17:15.669272+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}